Establishment of corporation to supply iPS cells for regenerative medicine September 12th, 23:01
Kyoto University established a new foundation this month in order to stably supply high-quality iPS cells for use in regenerative medicine to research institutions. iPS cells will be supplied by independent corporations while securing a certain level of profit in the future, instead of Kyoto University, which has been in charge of supply.
The newly established “Kyoto University iPS Cell Research Foundation” is based on research at Kyoto University, and aims to manufacture and supply iPS cells for use in regenerative medicine.
The corporation was established on the 6th of this month, and Director Shinya Yamanaka of the Kyoto University iPS Cell Research Institute was appointed as the representative director.
The iPS cells used in regenerative medicine have been supplied to research institutions nationwide with the project “iPS cell stock” with the support of Kyoto University so far, but the university will rely on the support of the country in the future. In order to maintain a stable supply without the need, we have sought that it is necessary to secure a certain level of profit with an independent corporation.
This policy was approved last month by the national expert committee and led to the establishment of this corporation. In order to realize regenerative medicine, the supply of high-quality iPS cells, which has been promoted as a national project, will secure excellent human resources for cell culture and management based on a certain amount of profit from an independent corporation. Will do while.